THERESA ROLNIAK: Open Payments
NPI 1952146672 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,343 in 61 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $458 · 2025 $1,343
Food & beverage: $1,243Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $653 |
| QOL Medical, LLC | 5 | $129 |
| Janssen Biotech, Inc. | 2 | $115 |
| Madrigal Pharmaceuticals | 2 | $93 |
| PFIZER INC. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Aimmune Therapeutics, Inc. | 2 | $56 |
| Ardelyx, Inc. | 3 | $54 |
| Lilly USA, LLC | 2 | $51 |
| Exact Sciences Corporation | 1 | $27 |
Products named: RINVOQ, SKYRIZI, Sucraid, TREMFYA, REZDIFFRA, CREON, VELSIPITY, VOWST.
Industry payments across NV — which companies pay providers there.
